Adriblastina RD
Brand Name: Adriblastina RD
Generic Name: Doxorubicin Hydrochloride
Active
Registration Number
DRP-3413
Dosage Form
Lyophilized Powder for Injection (IV)
Issuance Date
February 9, 2023
Expiry Date
February 9, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength50 mg
Packaging25 mL-Capacity Type I Colorless Glass Vial with chlorobutyl Rubber stopper and Aluminum Seal with a Polypropylene Flip-off Top (Box of 1's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic (Anthracycline)
A
Application
Initial
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Doxorubicin HydrochlorideActive
Monograph: Doxorubicin